Nippon India Pharma Fund – Direct Growth

Equity . Sectoral / Thematic
Monthly Amount Invested
Duration
Yr
  • Would Have Become
    --
  • Invested Value
    --
  • Total Gain
    --
  • Returns
    -- per annum
₹ 100 ₹ 5,000 1.04 % 0★ ₹ - 9 Years
Min SIP Min Lumpsum Expense Ratio Rating Fund Size Fund Age
₹ 100 ₹ 5,000 1.04 %
Min SIP Min Lumpsum Expense Ratio
0★ ₹ 1.04 Cr 9 Years
Rating Fund Size Fund Age

Scheme Performance

Returns and Ranks ( as on April 28.2022 )
1 Month1M 1 Year1Y 3 Years3Y 5 Years5Y
Trailing Returns -12.36% 23.69% 16.59% 15.90%
Category Average -13.65% -13.83% 9.96% -

Scheme Allocation

Holding
Sector
Asset
Sun Pharma.Inds.
13.91%
Cipla
9.23%
Dr Reddy's Labs
7.74%
Divi's Lab.
6.89%
Torrent Pharma.
6.63%
Others
55.6%
Healthcare Services
17.38%
Debt
1.96%
Cash & Others
-0.29%
Others
80.95%
Equity
98.33%
Reverse Repos
1.96%
Cash & Cash Equivalents
0.01%
Net Curr Ass/Net Receivables
-0.3%

Exit Load & Tax Implication

Exit Load 1% if redeemed or switchd out on or efore completion of 1 Months from the date of allotment of units. NIl if redeemed or switched out after the completion of 1 Months from the date of allotment of units.

Advance Ratio

-0.05 0.98 0.57 -0.04
Alpha SD Beta Sharpe

Risk-O-Meter

AMC Contact Details

Nippon India Mutual Fund
AUM:
2,85,196 Cr
Address:
4th Floor, Tower A, Peninsula Busines -s Park, Ganapatrao Kadam Marg Lower Parel (W), Mumbai - 400013.
Contact:
022-68087000/1860260111
Email ID:
customercare@nipponindiaim.in

Frequently Asked Questions

The NAV of Nippon India Pharma Fund – Direct Growth is ₹283.26 as of 27 June 2022.